San Gabriel, CA, United States of America

Kay T Khin

USPTO Granted Patents = 15 


 

Average Co-Inventor Count = 3.0

ph-index = 3

Forward Citations = 104(Granted Patents)


Company Filing History:


Years Active: 2007-2017

Loading Chart...
Loading Chart...
Loading Chart...
15 patents (USPTO):Explore Patents

Title: Innovations of Kay T Khin in Therapeutics Delivery

Introduction

Kay T Khin is an accomplished inventor based in San Gabriel, California, with a remarkable portfolio of 15 patents. Her work primarily focuses on the development of novel therapeutic compositions that enhance drug delivery systems.

Latest Patents

One of her latest patents involves cyclodextrin-based polymers designed for the delivery of small molecule therapeutics. This invention relates to compositions of therapeutic cyclodextrin-containing polymeric compounds that serve as carriers for these therapeutics. The polymers improve drug stability and solubility while reducing toxicity when used in vivo. By selecting various linker groups and targeting ligands, these polymers enable controlled delivery of therapeutic agents. Additionally, the invention outlines methods for treating subjects with these therapeutic compositions and includes strategies for conducting pharmaceutical business, such as manufacturing, licensing, or distributing related kits.

Career Highlights

Throughout her career, Kay T Khin has made significant contributions to the field of pharmaceuticals. She has worked with notable companies, including Cerulean Pharma Inc. and Insert Therapeutics, Inc. Her innovative approaches have positioned her as a key figure in therapeutic delivery systems.

Collaborations

Kay has collaborated with esteemed colleagues, including Jianjun Cheng and Mark E Davis, further enhancing her research and development efforts in the pharmaceutical industry.

Conclusion

Kay T Khin's innovative work in cyclodextrin-based polymers represents a significant advancement in therapeutic delivery systems. Her contributions continue to impact the field of pharmaceuticals positively.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…